532 related articles for article (PubMed ID: 19695365)
1. [Opiate replacement therapy in France: assessment of the public policies].
Chast F
Ann Pharm Fr; 2009 Sep; 67(5):299-303. PubMed ID: 19695365
[No Abstract] [Full Text] [Related]
2. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for opiate addiction.
J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
[No Abstract] [Full Text] [Related]
4. [Blessing or problem child? Substitution therapy for opiate-addicted patients].
Pallenbach E
Pharm Unserer Zeit; 2002; 31(1):90-5. PubMed ID: 11852662
[No Abstract] [Full Text] [Related]
5. Maintenance for opioid addiction with buprenorphine and methadone: "The only thing new in the world is the history you don't know".
Stimmel B
J Addict Dis; 2005; 24(3):1-6. PubMed ID: 16186079
[No Abstract] [Full Text] [Related]
6. Methadone vs naltrexone.
Blansfield HN
Conn Med; 1997 Jan; 61(1):53-4. PubMed ID: 9040159
[No Abstract] [Full Text] [Related]
7. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
Stimmel B
J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
[No Abstract] [Full Text] [Related]
8. [Buprenorphine or methadone for detoxification of young opioid addicts?].
Ebner R; Schreiber W; Zierer C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
[TBL] [Abstract][Full Text] [Related]
9. [Opiate substitution: the users' point of view].
Chappard P
Ann Pharm Fr; 2009 Sep; 67(5):365-8. PubMed ID: 19695373
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
11. [Opiate replacement therapy in France].
Gatignol C
Ann Pharm Fr; 2009 Sep; 67(5):360-4. PubMed ID: 19695372
[TBL] [Abstract][Full Text] [Related]
12. Regarding naltrexone for probationers and parolees.
Stancliff S
J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
[No Abstract] [Full Text] [Related]
13. Medical treatment of opioid dependence within the South African context.
Weich L
SADJ; 2010 May; 65(4):168-71. PubMed ID: 20632700
[No Abstract] [Full Text] [Related]
14. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.
Toce MS; Chai PR; Burns MM; Boyer EW
J Med Toxicol; 2018 Dec; 14(4):306-322. PubMed ID: 30377951
[TBL] [Abstract][Full Text] [Related]
15. Opiate maintenance alternatives: new studies.
Harv Ment Health Lett; 2005 Sep; 22(3):6. PubMed ID: 16224834
[No Abstract] [Full Text] [Related]
16. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
17. Expanded table: Some drugs for management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
[No Abstract] [Full Text] [Related]
18. Caring for patients with opioid dependence.
Bunker J; Winstock A; Zwar NA
Aust Fam Physician; 2008; 37(1-2):57-60. PubMed ID: 18239755
[TBL] [Abstract][Full Text] [Related]
19. Management of opioid withdrawal symptoms.
Med Lett Drugs Ther; 2018 Aug; 60(1554):137-141. PubMed ID: 30133420
[No Abstract] [Full Text] [Related]
20. [Opioid-related disorders].
Funada M
Ryoikibetsu Shokogun Shirizu; 2003; (40):480-3. PubMed ID: 14626165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
